Katherine has an exquisite instinct for understanding that there is a context to each patient’s diagnosis that is just as ...

Natalie Schnaitmann discusses urgent supportive care gaps younger women with cancer encounter, and how they affect long-term quality of life.

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

I reflect on finding peace, purpose and presence after my diagnosis through a creative writing exercise rooted in mindfulness ...

Iopofosine-131 received FDA breakthrough status for relapsed or refractory Waldenstrom macroglobulinemia, showing strong ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...